Target intelligence / Profile preview

Presenilin-1 (PSEN1 (also commonly abbreviated as PS-1))

Target
PSEN1 (also commonly abbreviated as PS-1)
Molecular classification
Enzyme, Protease (specifically, the catalytic subunit of the gamma-secretase complex), Other (Calcium-leak channel)
01

Overview

Presenilin‑1 is a multi-pass transmembrane protein encoded by the *PSEN1* gene. It serves as the **catalytic core** of the gamma-secretase complex, which is responsible for cleaving various type I transmembrane proteins, most notably amyloid precursor protein (APP). This cleavage generates amyloid beta peptides; accumulation and aggregation of these peptides are central features in Alzheimer's disease pathology. Mutations in *PSEN1* can lead to increased production of longer forms of amyloid beta that aggregate more readily, causing early-onset familial Alzheimer's disease. Presenilin‑1 also plays roles outside neurodegeneration—certain mutations have been linked to hidradenitis suppurativa via altered Notch signaling and impaired skin follicle function. Structurally, presenilin‑1 has nine transmembrane domains and undergoes endoproteolytic processing into N-terminal and C-terminal fragments that form an active heterodimer within cells[1][3].

Other names
PSEN1PS-1presenilin 1 protein
02

Mechanism of action

Inhibition or modulation of gamma-secretase activity to reduce amyloid beta production

03

Biological functions

Proteolysis of transmembrane proteinsGeneration of amyloid beta peptide from amyloid precursor protein (APP)Regulation of calcium homeostasis
04

Disease associations

Neurodegenerative disease (notably Alzheimer's disease)Skin disease (hidradenitis suppurativa)
05

Safety considerations

Potential for off-target effects due to broad role in proteolysis and cell signaling pathways

Beyond the preview

Go deeper on Presenilin-1 (PSEN1 (also commonly abbreviated as PS-1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presenilin-1 (PSEN1 (also commonly abbreviated as PS-1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call